$0.82
+0 (+0%)
At Close: Aug 17, 2022
Emerging Markets Report: A Time to Grow
12:19pm, Monday, 11'th Jan 2021
An Emerging Markets News Commentary
Cybin Partners with Kernel to Leverage its Breakthrough Neuroimaging Technology for Psychedelic Therapeutics
07:30am, Monday, 11'th Jan 2021
TORONTO--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (“Cybin”), a life sciences company focused on psychedelic therapeutics, is excited to announce that it has entered into an agreement with neurotech
Sign In
Buy CLXPF